Luminex Case Study- St. John Providence & ARIES

E0dd49a9 1835 403c b0f7 3acdbd9f521b

St. John Providence provides comprehensive prevention, primary care, and advanced treatment programs with more than 125 medical centers and six hospitals spanning four counties. They are committed to providing care to treat the entire person -- body, mind, and spirit. This philosophy of care underscores their heritage as a faith-based health system offering our patients so much more than medicine. St. John Providence is the largest provider of inpatient care in southeast Michigan and one of the largest employers in metro Detroit.

Ted E. Schutzbank, PhD, Technical Director, Special Testing and Microbiology and his team provide an overview of the St. John Providence laboratory in Gross Pointe, MI and how they have adopted the ARIES® System. Specifically, The ARIES platform has helped to make their molecular testing more streamlined. Additionally, being able to run various samples types for different assays at the same time is extremely beneficial. This helps get results back to doctors quicker who in turn can make quicker treatment decisions for their patients.

The ARIES® Systems are Luminex's sample to answer, real time PCR systems that are crafted to increase laboratory efficiency, ensure result accuracy, and fit seamlessly into today's lean laboratory. ARIES® allows your lab to control each aspect of the sample to answer testing process, from sample accessioning through result reporting.

ARIES® Bordetella Assay Overview

Pertussis is also known as whooping cough. The infection is known to cause life-threatening complications among infants and small children, leading to an estimated 195,000 deaths annually around the world.

For cases of suspected pertussis, a contagious bacterial disease that can be difficult to distinguish from other upper respiratory infections, the ARIES® Bordetella Assay detects Bordetella pertussis and Bordetella parapertussis DNA from nasopharyngeal swab specimens. The real-time PCR assay runs on ARIES® Systems to provide specific diagnostic results in less than two hours. The assay is CE Marked and FDA cleared for IVD use.